6230 articles
Review reveals how NAD+ precursors like NMN could restore heart function by fixing cellular energy production and reducing oxidative damage.
New research shows removing senescent cells with fisetin dramatically reduces dangerous heart rhythm disorders in aging rabbits.
Dasatinib plus quercetin cleared senescent cells and restored kidney function in diabetic mice, offering hope for human treatment.
GlycanDIA workflow enables precise detection of low-abundance glycans, uncovering distinct RNA glycosylation patterns.
New blood test identifies early-stage breast and lung cancers by measuring epigenetic chaos in cell-free DNA fragments.
International survey exposes significant disagreements among specialists on diagnosing growth hormone deficiency in children and adults.
Combination therapy with olaparib and irinotecan demonstrated activity in pediatric tumors, particularly those with genetic instability.
New study shows circulating tumor cells can predict treatment response and reveal drug resistance patterns.
Switching between different drug types prevents resistance in breast cancer therapy, offering hope for extended treatment options.
Large trial finds combination therapy doesn't improve survival or response rates compared to standard treatment alone.
Antibody-drug conjugate achieved 21% response rate in heavily pretreated patients with limited options.
Scientists identify TP53 and CYLD mutations that make HPV-positive head and neck cancers more aggressive and treatment-resistant.
